Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia
- PMID: 20564415
- DOI: 10.1002/cncr.25239
Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia
Comment on
-
Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia.Cancer. 2009 Oct 15;115(20):4839-48. doi: 10.1002/cncr.24535. Cancer. 2009. PMID: 19637341
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
